Literature DB >> 9680583

Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulfur colloid.

L R Goldfarb1, N P Alazraki, D Eshima, L A Eshima, S C Herda, R K Halkar.   

Abstract

PURPOSE: To evaluate the use of 0.22-micron filtration of technetium-99m sulfur colloid particles in the optimization of lymphoscintigraphy.
MATERIALS AND METHODS: Forty-one consecutive lymphoscintigraphic studies obtained with 0.22-micron filtration of Tc-99m sulfur colloid in 41 patients (26 men, 15 women; average age, 55.4 years) and 41 consecutive studies obtained with 5.0-micron filtration in 41 patients (20 men, 21 women; average age, 54.5 years) were retrospectively, randomly reviewed. Studies were evaluated for lymphatic channel depiction and sentinel lymph node depiction. Studies included immediate flow images (obtained at 10 seconds per frame) and multiview static images obtained up to 2 hours after intradermal Tc-99m sulfur colloid injection.
RESULTS: The number of drainage beds visualized was 52 with 5.0-micron filtration and 51 with 0.22-micron filtration (P = .570). The number of lymphatic channels visualized was 45 with 5.0-micron filtration and 75 with 0.22-micron filtration (P = .006). The number of lymph nodes visualized was 102 with 5.0-micron filtration and 123 with 0.22-micron filtration (P = .123). The number of studies judged as optimal (i.e., depicted lymphatic channels leading to sentinel nodes) was 10 with 5.0-micron filtration and 19 with 0.22-micron filtration (P = .038). The number of studies with depicted lymph nodes but no depicted lymphatic channel was 15 with 5.0-micron filtration and six with 0.22-micron filtration (P = .023).
CONCLUSION: The use of 0.22-micron filtration in the preparation of Tc-99m sulfur colloid substantially improves study quality and increases the diagnostic certainty in the identification of sentinel lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9680583     DOI: 10.1148/radiology.208.2.9680583

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Contrast-enhanced sonography for detection of secondary lymph nodes in a melanoma tumor animal model.

Authors:  Ji-Bin Liu; Daniel A Merton; Adam C Berger; Flemming Forsberg; Agnieszka Witkiewicz; Hongjia Zhao; John R Eisenbrey; Traci B Fox; Barry B Goldberg
Journal:  J Ultrasound Med       Date:  2014-06       Impact factor: 2.153

2.  Preoperative sentinel lymph node localization in vulvar cancer: preliminary experience with inguinal intradermal contrast-enhanced ultrasound.

Authors:  O Lahtinen; M Eloranta; M Anttila; H Kärkkäinen; R Sironen; R Vanninen; S Rautiainen
Journal:  Eur Radiol       Date:  2017-11-30       Impact factor: 5.315

3.  Percutaneous contrast-enhanced ultrasound for localization and qualitative diagnosis of sentinel lymph nodes in cutaneous malignant melanoma of lower extremities: a preliminary study.

Authors:  Rui-Qian Guo; Xi Xiang; Li-Yun Wang; Bi-Hui Zhu; Song-Ya Huang; Xin-Yi Tang; Jun-Jie Chen; Li Qiu
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Preoperative localization of sentinel lymph nodes using percutaneous contrast-enhanced ultrasonography in patients with breast cancer.

Authors:  Yi-Lin Xu; Xue-Jing Liu; Ying Zhu; Hong Lu
Journal:  Gland Surg       Date:  2022-02

5.  99mTc-labeled sodium phytate and stannous chloride injection accurately detects sentinel lymph node in axillary of early stage breast cancer: a randomized, controlled study.

Authors:  Suisheng Yang; Weiyu Bao; Xiaorong Bai; Chen Gao; Binming Zhang; Zhuanji Jiang
Journal:  Onco Targets Ther       Date:  2018-04-04       Impact factor: 4.147

6.  Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.

Authors:  Jian Liu; Xiaoling Liu; Jiao He; Bo Gou; Yujie Luo; Sihui Deng; Hong Wen; Lin Zhou
Journal:  Sci Rep       Date:  2019-09-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.